Minireviews
Copyright ©The Author(s) 2025.
World J Clin Oncol. Jun 24, 2025; 16(6): 106629
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.106629
Table 3 Characteristics of the Oslo, Fong, and Eastern Cooperative Oncology Group scoring systems
Score
Component
Scoring/criteria
Cutoff
Clinical interpretation
OsloTumor size> 5.5 cm = 1 point≥ 2 pointsHigher recurrence risk post-LT
CEA level> 80 ng/mL = 1 point
Time from primary to LT< 2 years = 1 point
Response to chemotherapy< 10% shrinkage = 1 point
FongNodal status of primaryPositive = 1 point≥ 3 pointsWorse prognosis post-resection
Disease-free interval< 12 months = 1 point
Number of liver metastases> 1 = 1 point
CEA level> 200 ng/mL = 1 point
Largest tumor> 5 cm = 1 point
ECOGPerformance status0 = fully active; 1 = symptomatic but completely ambulatory; 2 = symptomatic, < 50% in bed during the day; 3 = symptomatic, > 50% in bed, but not bedbound; 4 = bedridden≥ 2 = ineligibleStratifies fitness for treatment or surgery